US Stock MarketDetailed Quotes

ANIX Anixa Biosciences

Watchlist
  • 2.890
  • -0.240-7.67%
Close Jul 23 16:00 ET
  • 2.890
  • 0.0000.00%
Post 16:52 ET
92.50MMarket Cap-7810P/E (TTM)

About Anixa Biosciences Company

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Company Profile

SymbolANIX
Company NameAnixa Biosciences
Listing DateJul 10, 2015
Issue Price10.00
Founded1982
CEODr. Amit Kumar,PhD
MarketNASDAQ
Employees5
Securities TypeOrdinary Shares
Fiscal Year Ends10-31
Address3150 Almaden Expressway,Suite 250
CitySan Jose
ProvinceCalifornia
CountryUnited States of America
Zip Code95118
Phone1-408-708-9808

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Amit Kumar,PhD
  • Chairman of the Board and Chief Executive Officer
  • 3.64M
  • Michael J. Catelani
  • President, Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
  • 1.97M
  • Lewis H. Titterton, Jr
  • Lead Independent Director
  • 169.35K
  • Dr. Arnold Baskies, M.D.
  • Independent Director
  • 169.35K
  • Emily Gottschalk
  • Independent Director
  • 169.35K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg